Stability of measurement of the immature platelet fraction

American Journal of Hematology

Volumn 85, Issue 8, 2010, Pages 622-624

  Ruisi, Mary M ^a   Psaila, Bethan ^a,b   Ward, Mary J ^a   Villarica, Glynnis ^a   Bussel, James B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; COLORING AGENT; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD ANALYSIS; CHILD; CLINICAL PRACTICE; CLINICAL TRIAL; FEMALE; HUMAN; IMMATURE PLATELET FRACTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHLEBOTOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; ROOM TEMPERATURE; SCHOOL CHILD; THROMBOCYTE ANOMALY; THROMBOCYTOPOIESIS; VEIN PUNCTURE; BLOOD; BLOOD STORAGE; CHEMISTRY; COMPARATIVE STUDY; FLOW CYTOMETRY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSTRUMENTATION; LABORATORY DIAGNOSIS; LASER; LETTER; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; REPRODUCIBILITY; THROMBOCYTE; THROMBOCYTE COUNT; TIME; ULTRASTRUCTURE; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; BLOOD PRESERVATION; CHILD; CHILD, PRESCHOOL; COLORING AGENTS; FEMALE; FLOW CYTOMETRY; HUMANS; LASERS; MALE; MIDDLE AGED; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SPECIMEN HANDLING; THROMBOPOIESIS; TIME FACTORS; YOUNG ADULT;

EID: 77955501269     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21748     Document Type: Article

References (21)

1. Cooper N, Bussel J. The pathogenesis of immune thrombocytopenic purpura. Br J Haematol 2006;122:364-374.
2. Chang M, Nakagawa PA, Williams SA, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 2003;102:887-895.
3. McMillan R, Wang L, Tomer A, et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004;103:1364-1369.
4. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
5. Provan D, Stasi R, Newland A, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115(2):168-186.
6. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcomes in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009;113:2286-2393.
7. Ingram M, Coopersmith S. Reticulated platelets following blood loss. Br J Haematol 1969;17:225-228.
8. Lee LG, Chen CH, Chiu LA. Thiazole orange, a new dye for reticulocyte analysis. Cytometery 1986;7:508-517.
9. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocytopenic patients. Blood 1990;75:116-121.
10. Ault K, Rinder HM, Mitchell J, et al. The significance of platelets with increased RNA content (reticulated platelets): A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992;98:637-646.
11. Rinder HM, Munz UJ, Ault KA, et al. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med 1993;117:606-610.
12. Briggs C, Kunka S, Hart D, et al. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004;126:93-96.
13. Sakakura M, Wada H, Abe Y, et al. Usefulness of measurement of reticulated platelets for diagnosis of idiopathic thrombocytopenic purpura. J Clin Appl Thromb/Hemostasis 2005;11:253-261. (Pubitemid 41022854)
14. Saxon BR, Blanchette VS, Butchart S, et al. Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura. J Pediatr Hematol/Oncol 1998;20:44-48.
15. Takubo T, Yamane T, Hino M, et al. Clinical significance of simultaneous measurement of reticulated platelets and large platelets in idiopathic thrombocytopenic purpura. Haematologica 2000;30:183-192.
16. Stasi R, Evangelista ML, Amadori S. Novel thrombopoietic agents: A review of their use in idiopathic thrombocytopenic purpura. Drugs 2008;68:901-912.
17. Kobos R, Bussel JB. Overview of thrombopoietic agents in the treatment of thrombocytopenia. Clin Lymphoma Myeloma 2008;8:33-43.
18. Kuter DJ. New drugs for familiar therapeutic targets: Thrombopoietin receptor agonists and immune thrombocytopenic purpura. Eur J Haematol Suppl 2008;80(69): 9-18.
19. Watanabe K, Tateuchi K, Kawai Y, et al. Automated measurement of reticulated platelets in estimating thrombopoiesis. Eur J Haematol 1995;54:163-171.
20. Sysmex Home Page. Our products: Sysmex XE-2100 automated hematology analyzer, Kobe, Japan. Available at:www.sysmex.com/usa/ourproducts. Accessed on June 3, 2007.
21. Koh KR, Yamane T, Ohta K, et al. Pathophysiological significance of simultaneous measurement of reticulated platelets, large platelets and serum thrombopoietin in non-neoplastic thrombocytopenic disorders. Eur J Haematol Suppl 2008;63(5): 295-301.